The AIRAscore structure software uses the latest technical possibilities and measures the brain volume and its changes on the basis of MRI image data of the head.
The result is an evaluation report with precise measured values of various brain structures that are important for diagnostics.
Your doctor can use these objective measured and comparative values for his findings like a kind of ‘second opinion’ and incorporate them into his diagnosis.
Early diagnosis, better and more reliable differential diagnoses as well as individual therapies are thus made easier – or even possible in the first place.
An excerpt of our references
‘Especially in the case of rare neurological diseases, we are often faced with the problem of whether an individual brain scan is already conspicuous or not. AIRAscore provides great help in our daily work.’
Prof. Dr. Ludger Schöls
Neurologist, University Hospital of Tübingen, Germany
‘I am pleased to be able to offer my patients the additional service provided by AIRAscore. Experience shows that very many patients are afraid of dementia in old age. AIRAscore helps me to distinguish healthy from sick aging and I recognize much earlier than with the pure visual findings whether and when concrete action is needed.’
Dr. Nicola Meyer
Radiologist, Hamburg, Germany
‘I am pleased that with AIRAscore structure we now have a way to benefit from the latest scientific findings in our private practice. It only takes a few minutes until I have exact measurement values directly in my PACS, which significantly improve my reporting options.’
PD Dr. Hansjörg Rempp
Radiologist, Stuttgart, Germany
‘The quantitative assessment of brain volume is becoming increasingly important. Objectively verifiable measured values are the basis for any personalised treatment tailored to the individual patient. AIRAmed fills this gap in personalised healthcare through machine learning.’
Prof. Dr. Matthis Synofzik
Neurologist, University Hospital of Tübingen, Germany
‘We now use AIRAscore structure routinely with our inpatients. The findings report gives us the necessary security here in the assessment of dementia-related diseases.’
Prof. Dr. Gerhard Eschweiler
Psychiatrist, University Hospital of Tübingen, Germany